IDYA vs. RXRX

Last updated Jun 3, 2026

IDYA (IDEAYA Biosciences, Inc.) and RXRX (Recursion Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, IDYA returned 6.44%/yr vs -33.81%/yr for RXRX. At a 0.42 correlation, their price movements are largely independent.

Performance

IDYA vs. RXRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in IDEAYA Biosciences, Inc. (IDYA) and Recursion Pharmaceuticals, Inc. (RXRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IDYA achieves a -19.38% return, which is significantly lower than RXRX's -11.74% return.

IDYA

• 1D: -3.70%
• 1M: -1.14%
• YTD: -19.38%
• 6M: -17.28%
• 1Y: 31.34%
• 3Y*: 3.87%
• 5Y*: 6.44%
• 10Y*: —

RXRX

• 1D: -4.75%
• 1M: 6.49%
• YTD: -11.74%
• 6M: -16.44%
• 1Y: -17.39%
• 3Y*: -24.02%
• 5Y*: -33.81%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IDYA vs. RXRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IDYA IDEAYA Biosciences, Inc.	-19.38%	34.51%	-27.77%	95.82%	-23.14%	27.03%
RXRX Recursion Pharmaceuticals, Inc.	-11.74%	-39.50%	-31.44%	27.89%	-54.99%	-45.27%

Correlation

The correlation between IDYA and RXRX is 0.43, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.43
Correlation (3Y) Calculated over the trailing 3-year period	0.40
Correlation (5Y) Calculated over the trailing 5-year period	0.42
Correlation (All Time) Calculated using the full available price history since Apr 19, 2021	0.42

Fundamentals

Market Cap IDYA : $2.47B RXRX : $1.91B
EPS IDYA : -$1.58 RXRX : -$1.17
PS Ratio IDYA : 10.99 RXRX : 26.15
PB Ratio IDYA : 2.64 RXRX : 1.86
Total Revenue (TTM) IDYA : $225.27M RXRX : $66.29M
Gross Profit (TTM) IDYA : $215.25M RXRX : -$22.83M
EBITDA (TTM) IDYA : -$157.90M RXRX : -$505.90M

Return for Risk

IDYA vs. RXRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDYA

IDYA Risk / Return Rank: 63
IDYA Sharpe Ratio Rank: 63
IDYA Sortino Ratio Rank: 59
IDYA Omega Ratio Rank: 57
IDYA Calmar Ratio Rank: 68
IDYA Martin Ratio Rank: 68

RXRX

RXRX Risk / Return Rank: 32
RXRX Sharpe Ratio Rank: 31
RXRX Sortino Ratio Rank: 33
RXRX Omega Ratio Rank: 32
RXRX Calmar Ratio Rank: 32
RXRX Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IDYA vs. RXRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for IDEAYA Biosciences, Inc. (IDYA) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IDYA	RXRX	Difference
Sharpe ratio Return per unit of total volatility	0.69	-0.24	+0.93
Sortino ratio Return per unit of downside risk	1.27	0.16	+1.11
Omega ratio Gain probability vs. loss probability	1.15	1.02	+0.13
Calmar ratio Return relative to maximum drawdown	1.52	-0.23	+1.75
Martin ratio Return relative to average drawdown	3.57	-0.39	+3.96
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IDYA vs. RXRX - Sharpe Ratio Comparison

The current IDYA Sharpe Ratio is 0.69, which is higher than the RXRX Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of IDYA and RXRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IDYA	RXRX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.69	-0.24	+0.93
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	-0.36	+0.47
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	-0.37	+0.56

Drawdowns

IDYA vs. RXRX - Drawdown Comparison

The maximum IDYA drawdown since its inception was -74.64%, smaller than the maximum RXRX drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for IDYA and RXRX.

Drawdown Indicators

	IDYA	RXRX	Difference
Max Drawdown Largest peak-to-trough decline	-74.64%	-93.13%	+18.49%
Max Drawdown (1Y) Largest decline over 1 year	-26.39%	-58.17%	+31.78%
Max Drawdown (3Y) Largest decline over 3 years	-69.23%	-82.09%	+12.86%
Max Drawdown (5Y) Largest decline over 5 years	-69.42%	-93.13%	+23.71%
Current Drawdown Current decline from peak	-40.87%	-91.27%	+50.40%
Average Drawdown Average peak-to-trough decline	-30.95%	-75.33%	+44.38%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.23%	35.04%	-23.81%

Volatility

IDYA vs. RXRX - Volatility Comparison

The current volatility for IDEAYA Biosciences, Inc. (IDYA) is 8.22%, while Recursion Pharmaceuticals, Inc. (RXRX) has a volatility of 18.74%. This indicates that IDYA experiences smaller price fluctuations and is considered to be less risky than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IDYA	RXRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.22%	18.74%	-10.52%
Volatility (6M) Calculated over the trailing 6-month period	30.77%	44.79%	-14.02%
Volatility (1Y) Calculated over the trailing 1-year period	46.05%	73.46%	-27.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	58.97%	93.46%	-34.49%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	73.86%	93.62%	-19.76%

Dividends

IDYA vs. RXRX - Dividend Comparison

Neither IDYA nor RXRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both IDYA and RXRX in my portfolio?

IDYA and RXRX have a correlation of 0.43, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IDYA or RXRX?

RXRX has higher volatility (18.74%) compared to IDYA (8.22%). In terms of maximum drawdown, IDYA dropped -74.64% vs RXRX's -93.13%.

Which has better risk-adjusted returns?

IDYA currently has the higher Sharpe Ratio (0.69 vs -0.24), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.